NQF Statement on U.S. Department of Justice Settlement with Charles Denham 

Washington, DC – The U.S. Department of Justice (DOJ) settlement announced today with Dr. Charles Denham for $1 million brings to a close an unprecedented, unwelcome chapter in the nation’s efforts to advance patient safety.  

The DOJ press release acknowledges that former NQF committee co-chair Dr. Charles Denham did not disclose his commercial ties, as required by NQF’s conflict of interest policies.

Upon discovering those ties, NQF took immediate steps to strengthen its processes to ensure the integrity of quality measures and safe practices, and has continued to evolve and strengthen its COI policies. NQF remains committed to endorsing measures and safe practices that are of the highest quality.